Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2024-09-05 Report Publication Anno…
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming 'Corporate Presentation' (IR) event. It provides details such as the date, location, target audience, and purpose of the meeting. According to the 'Menu vs Meal' rule, since this is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a regulatory announcement regarding company activities.
2024-09-05 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This document details the company's plan to sell its own shares to raise capital. According to the provided filing definitions, a report detailing the company buying back or selling its own shares is classified as 'Transaction in Own Shares' (POS).
2024-08-29 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '코아스템켐온 주식회사' covering the period from January 1, 2024, to June 30, 2024. It contains comprehensive financial data, business operations, management discussions, and organizational details. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) containing actual financial statements and analysis is classified as an Interim / Quarterly Report (IR). H1 2024
2024-08-14 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 1% confidence The document is a regulatory disclosure regarding a derivative trading loss (파생상품거래손실발생) filed by Corestemchemon. It details the financial impact of derivative valuation losses related to exchangeable bonds. Since this is a specific regulatory disclosure of a material financial event that does not fit into categories like earnings releases, annual reports, or management changes, it falls under the general regulatory filing category.
2024-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required under the Capital Markets Act when an individual or entity acquires or changes a significant stake (typically 5% or more) in a listed company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2024-07-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a specific individual (Kwang Sun Kwon) in Corestemchemone Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by company directors/executives, which corresponds to the 'Director's Dealing' category.
2024-07-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.